nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—Hypersensitivity—Azathioprine—systemic scleroderma	0.000228	0.000228	CcSEcCtD
Escitalopram—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000228	0.000228	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000228	0.000228	CcSEcCtD
Escitalopram—Insomnia—Lisinopril—systemic scleroderma	0.000228	0.000228	CcSEcCtD
Escitalopram—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000227	0.000227	CcSEcCtD
Escitalopram—Paraesthesia—Lisinopril—systemic scleroderma	0.000226	0.000226	CcSEcCtD
Escitalopram—Vomiting—Captopril—systemic scleroderma	0.000226	0.000226	CcSEcCtD
Escitalopram—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000225	0.000225	CcSEcCtD
Escitalopram—Dyspnoea—Lisinopril—systemic scleroderma	0.000224	0.000224	CcSEcCtD
Escitalopram—Rash—Captopril—systemic scleroderma	0.000224	0.000224	CcSEcCtD
Escitalopram—Dermatitis—Captopril—systemic scleroderma	0.000224	0.000224	CcSEcCtD
Escitalopram—Somnolence—Lisinopril—systemic scleroderma	0.000224	0.000224	CcSEcCtD
Escitalopram—Headache—Captopril—systemic scleroderma	0.000223	0.000223	CcSEcCtD
Escitalopram—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000222	0.000222	CcSEcCtD
Escitalopram—Dyspepsia—Lisinopril—systemic scleroderma	0.000222	0.000222	CcSEcCtD
Escitalopram—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000221	0.000221	CcSEcCtD
Escitalopram—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000221	0.000221	CcSEcCtD
Escitalopram—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00022	0.00022	CcSEcCtD
Escitalopram—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00022	0.00022	CcSEcCtD
Escitalopram—Asthma—Methotrexate—systemic scleroderma	0.00022	0.00022	CcSEcCtD
Escitalopram—Infection—Mycophenolate mofetil—systemic scleroderma	0.000219	0.000219	CcSEcCtD
Escitalopram—Decreased appetite—Lisinopril—systemic scleroderma	0.000219	0.000219	CcSEcCtD
Escitalopram—Eosinophilia—Methotrexate—systemic scleroderma	0.000217	0.000217	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000217	0.000217	CcSEcCtD
Escitalopram—Fatigue—Lisinopril—systemic scleroderma	0.000217	0.000217	CcSEcCtD
Escitalopram—Shock—Mycophenolate mofetil—systemic scleroderma	0.000217	0.000217	CcSEcCtD
Escitalopram—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000216	0.000216	CcSEcCtD
Escitalopram—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000216	0.000216	CcSEcCtD
Escitalopram—Hypersensitivity—Leflunomide—systemic scleroderma	0.000216	0.000216	CcSEcCtD
Escitalopram—Pancreatitis—Methotrexate—systemic scleroderma	0.000215	0.000215	CcSEcCtD
Escitalopram—Pain—Lisinopril—systemic scleroderma	0.000215	0.000215	CcSEcCtD
Escitalopram—Constipation—Lisinopril—systemic scleroderma	0.000215	0.000215	CcSEcCtD
Escitalopram—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000215	0.000215	CcSEcCtD
Escitalopram—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000214	0.000214	CcSEcCtD
Escitalopram—Bradycardia—Prednisone—systemic scleroderma	0.000214	0.000214	CcSEcCtD
Escitalopram—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000213	0.000213	CcSEcCtD
Escitalopram—Diarrhoea—Azathioprine—systemic scleroderma	0.000212	0.000212	CcSEcCtD
Escitalopram—Haemoglobin—Prednisone—systemic scleroderma	0.000211	0.000211	CcSEcCtD
Escitalopram—Nausea—Captopril—systemic scleroderma	0.000211	0.000211	CcSEcCtD
Escitalopram—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000211	0.000211	CcSEcCtD
Escitalopram—Haemorrhage—Prednisone—systemic scleroderma	0.00021	0.00021	CcSEcCtD
Escitalopram—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00021	0.00021	CcSEcCtD
Escitalopram—Asthenia—Leflunomide—systemic scleroderma	0.00021	0.00021	CcSEcCtD
Escitalopram—Hallucination—Prednisone—systemic scleroderma	0.000209	0.000209	CcSEcCtD
Escitalopram—Pancytopenia—Methotrexate—systemic scleroderma	0.000209	0.000209	CcSEcCtD
Escitalopram—Feeling abnormal—Lisinopril—systemic scleroderma	0.000207	0.000207	CcSEcCtD
Escitalopram—Pruritus—Leflunomide—systemic scleroderma	0.000207	0.000207	CcSEcCtD
Escitalopram—Connective tissue disorder—Prednisone—systemic scleroderma	0.000207	0.000207	CcSEcCtD
Escitalopram—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000206	0.000206	CcSEcCtD
Escitalopram—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000206	0.000206	CcSEcCtD
Escitalopram—Dysuria—Methotrexate—systemic scleroderma	0.000205	0.000205	CcSEcCtD
Escitalopram—Dizziness—Azathioprine—systemic scleroderma	0.000205	0.000205	CcSEcCtD
Escitalopram—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000204	0.000204	CcSEcCtD
Escitalopram—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000202	0.000202	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000201	0.000201	CcSEcCtD
Escitalopram—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.0002	0.0002	CcSEcCtD
Escitalopram—Asthenia—Mycophenolic acid—systemic scleroderma	0.0002	0.0002	CcSEcCtD
Escitalopram—Diarrhoea—Leflunomide—systemic scleroderma	0.0002	0.0002	CcSEcCtD
Escitalopram—Urticaria—Lisinopril—systemic scleroderma	0.0002	0.0002	CcSEcCtD
Escitalopram—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000199	0.000199	CcSEcCtD
Escitalopram—Abdominal pain—Lisinopril—systemic scleroderma	0.000199	0.000199	CcSEcCtD
Escitalopram—Body temperature increased—Lisinopril—systemic scleroderma	0.000199	0.000199	CcSEcCtD
Escitalopram—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000198	0.000198	CcSEcCtD
Escitalopram—Pruritus—Mycophenolic acid—systemic scleroderma	0.000198	0.000198	CcSEcCtD
Escitalopram—Vomiting—Azathioprine—systemic scleroderma	0.000197	0.000197	CcSEcCtD
Escitalopram—Pneumonia—Methotrexate—systemic scleroderma	0.000197	0.000197	CcSEcCtD
Escitalopram—Eye disorder—Prednisone—systemic scleroderma	0.000197	0.000197	CcSEcCtD
Escitalopram—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000197	0.000197	CcSEcCtD
Escitalopram—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000196	0.000196	CcSEcCtD
Escitalopram—Infestation NOS—Methotrexate—systemic scleroderma	0.000196	0.000196	CcSEcCtD
Escitalopram—Infestation—Methotrexate—systemic scleroderma	0.000196	0.000196	CcSEcCtD
Escitalopram—Rash—Azathioprine—systemic scleroderma	0.000196	0.000196	CcSEcCtD
Escitalopram—Dermatitis—Azathioprine—systemic scleroderma	0.000195	0.000195	CcSEcCtD
Escitalopram—Depression—Methotrexate—systemic scleroderma	0.000195	0.000195	CcSEcCtD
Escitalopram—Flushing—Prednisone—systemic scleroderma	0.000195	0.000195	CcSEcCtD
Escitalopram—Headache—Azathioprine—systemic scleroderma	0.000194	0.000194	CcSEcCtD
Escitalopram—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000194	0.000194	CcSEcCtD
Escitalopram—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000194	0.000194	CcSEcCtD
Escitalopram—Dizziness—Leflunomide—systemic scleroderma	0.000194	0.000194	CcSEcCtD
Escitalopram—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000192	0.000192	CcSEcCtD
Escitalopram—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000191	0.000191	CcSEcCtD
Escitalopram—Stomatitis—Methotrexate—systemic scleroderma	0.000191	0.000191	CcSEcCtD
Escitalopram—Angiopathy—Prednisone—systemic scleroderma	0.000191	0.000191	CcSEcCtD
Escitalopram—Conjunctivitis—Methotrexate—systemic scleroderma	0.00019	0.00019	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00019	0.00019	CcSEcCtD
Escitalopram—Immune system disorder—Prednisone—systemic scleroderma	0.00019	0.00019	CcSEcCtD
Escitalopram—Pain—Mycophenolate mofetil—systemic scleroderma	0.000189	0.000189	CcSEcCtD
Escitalopram—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000189	0.000189	CcSEcCtD
Escitalopram—Arrhythmia—Prednisone—systemic scleroderma	0.000188	0.000188	CcSEcCtD
Escitalopram—Sweating—Methotrexate—systemic scleroderma	0.000188	0.000188	CcSEcCtD
Escitalopram—Haematuria—Methotrexate—systemic scleroderma	0.000187	0.000187	CcSEcCtD
Escitalopram—Vomiting—Leflunomide—systemic scleroderma	0.000186	0.000186	CcSEcCtD
Escitalopram—Alopecia—Prednisone—systemic scleroderma	0.000186	0.000186	CcSEcCtD
Escitalopram—Hypersensitivity—Lisinopril—systemic scleroderma	0.000185	0.000185	CcSEcCtD
Escitalopram—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000185	0.000185	CcSEcCtD
Escitalopram—Dizziness—Mycophenolic acid—systemic scleroderma	0.000185	0.000185	CcSEcCtD
Escitalopram—Epistaxis—Methotrexate—systemic scleroderma	0.000185	0.000185	CcSEcCtD
Escitalopram—Rash—Leflunomide—systemic scleroderma	0.000185	0.000185	CcSEcCtD
Escitalopram—Dermatitis—Leflunomide—systemic scleroderma	0.000184	0.000184	CcSEcCtD
Escitalopram—Mental disorder—Prednisone—systemic scleroderma	0.000184	0.000184	CcSEcCtD
Escitalopram—Nausea—Azathioprine—systemic scleroderma	0.000184	0.000184	CcSEcCtD
Escitalopram—Headache—Leflunomide—systemic scleroderma	0.000183	0.000183	CcSEcCtD
Escitalopram—Erythema—Prednisone—systemic scleroderma	0.000183	0.000183	CcSEcCtD
Escitalopram—Malnutrition—Prednisone—systemic scleroderma	0.000183	0.000183	CcSEcCtD
Escitalopram—Agranulocytosis—Methotrexate—systemic scleroderma	0.000183	0.000183	CcSEcCtD
Escitalopram—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000182	0.000182	CcSEcCtD
Escitalopram—Asthenia—Lisinopril—systemic scleroderma	0.000181	0.000181	CcSEcCtD
Escitalopram—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00018	0.00018	CcSEcCtD
Escitalopram—Pruritus—Lisinopril—systemic scleroderma	0.000178	0.000178	CcSEcCtD
Escitalopram—Vomiting—Mycophenolic acid—systemic scleroderma	0.000178	0.000178	CcSEcCtD
Escitalopram—Haemoglobin—Methotrexate—systemic scleroderma	0.000177	0.000177	CcSEcCtD
Escitalopram—Rash—Mycophenolic acid—systemic scleroderma	0.000176	0.000176	CcSEcCtD
Escitalopram—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000176	0.000176	CcSEcCtD
Escitalopram—Haemorrhage—Methotrexate—systemic scleroderma	0.000176	0.000176	CcSEcCtD
Escitalopram—Hepatitis—Methotrexate—systemic scleroderma	0.000176	0.000176	CcSEcCtD
Escitalopram—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000175	0.000175	CcSEcCtD
Escitalopram—Headache—Mycophenolic acid—systemic scleroderma	0.000175	0.000175	CcSEcCtD
Escitalopram—Pharyngitis—Methotrexate—systemic scleroderma	0.000174	0.000174	CcSEcCtD
Escitalopram—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000174	CcSEcCtD
Escitalopram—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000174	CcSEcCtD
Escitalopram—Nausea—Leflunomide—systemic scleroderma	0.000174	0.000174	CcSEcCtD
Escitalopram—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000174	0.000174	CcSEcCtD
Escitalopram—Vision blurred—Prednisone—systemic scleroderma	0.000173	0.000173	CcSEcCtD
Escitalopram—Urethral disorder—Methotrexate—systemic scleroderma	0.000172	0.000172	CcSEcCtD
Escitalopram—Diarrhoea—Lisinopril—systemic scleroderma	0.000172	0.000172	CcSEcCtD
Escitalopram—Ill-defined disorder—Prednisone—systemic scleroderma	0.00017	0.00017	CcSEcCtD
Escitalopram—Visual impairment—Methotrexate—systemic scleroderma	0.000169	0.000169	CcSEcCtD
Escitalopram—Anaemia—Prednisone—systemic scleroderma	0.000169	0.000169	CcSEcCtD
Escitalopram—Agitation—Prednisone—systemic scleroderma	0.000168	0.000168	CcSEcCtD
Escitalopram—Angioedema—Prednisone—systemic scleroderma	0.000167	0.000167	CcSEcCtD
Escitalopram—Dizziness—Lisinopril—systemic scleroderma	0.000166	0.000166	CcSEcCtD
Escitalopram—Erythema multiforme—Methotrexate—systemic scleroderma	0.000166	0.000166	CcSEcCtD
Escitalopram—Nausea—Mycophenolic acid—systemic scleroderma	0.000166	0.000166	CcSEcCtD
Escitalopram—Malaise—Prednisone—systemic scleroderma	0.000165	0.000165	CcSEcCtD
Escitalopram—Vertigo—Prednisone—systemic scleroderma	0.000165	0.000165	CcSEcCtD
Escitalopram—Eye disorder—Methotrexate—systemic scleroderma	0.000164	0.000164	CcSEcCtD
Escitalopram—Syncope—Prednisone—systemic scleroderma	0.000164	0.000164	CcSEcCtD
Escitalopram—Tinnitus—Methotrexate—systemic scleroderma	0.000164	0.000164	CcSEcCtD
Escitalopram—Cardiac disorder—Methotrexate—systemic scleroderma	0.000163	0.000163	CcSEcCtD
Escitalopram—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000162	0.000162	CcSEcCtD
Escitalopram—Loss of consciousness—Prednisone—systemic scleroderma	0.000161	0.000161	CcSEcCtD
Escitalopram—Vomiting—Lisinopril—systemic scleroderma	0.00016	0.00016	CcSEcCtD
Escitalopram—Angiopathy—Methotrexate—systemic scleroderma	0.00016	0.00016	CcSEcCtD
Escitalopram—Immune system disorder—Methotrexate—systemic scleroderma	0.000159	0.000159	CcSEcCtD
Escitalopram—Rash—Lisinopril—systemic scleroderma	0.000159	0.000159	CcSEcCtD
Escitalopram—Convulsion—Prednisone—systemic scleroderma	0.000159	0.000159	CcSEcCtD
Escitalopram—Dermatitis—Lisinopril—systemic scleroderma	0.000159	0.000159	CcSEcCtD
Escitalopram—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000158	0.000158	CcSEcCtD
Escitalopram—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000158	0.000158	CcSEcCtD
Escitalopram—Hypertension—Prednisone—systemic scleroderma	0.000158	0.000158	CcSEcCtD
Escitalopram—Chills—Methotrexate—systemic scleroderma	0.000158	0.000158	CcSEcCtD
Escitalopram—Headache—Lisinopril—systemic scleroderma	0.000158	0.000158	CcSEcCtD
Escitalopram—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000156	0.000156	CcSEcCtD
Escitalopram—Myalgia—Prednisone—systemic scleroderma	0.000156	0.000156	CcSEcCtD
Escitalopram—Arthralgia—Prednisone—systemic scleroderma	0.000156	0.000156	CcSEcCtD
Escitalopram—Anxiety—Prednisone—systemic scleroderma	0.000155	0.000155	CcSEcCtD
Escitalopram—Alopecia—Methotrexate—systemic scleroderma	0.000155	0.000155	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000155	0.000155	CcSEcCtD
Escitalopram—Discomfort—Prednisone—systemic scleroderma	0.000154	0.000154	CcSEcCtD
Escitalopram—Mental disorder—Methotrexate—systemic scleroderma	0.000154	0.000154	CcSEcCtD
Escitalopram—Erythema—Methotrexate—systemic scleroderma	0.000153	0.000153	CcSEcCtD
Escitalopram—Malnutrition—Methotrexate—systemic scleroderma	0.000153	0.000153	CcSEcCtD
Escitalopram—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000151	0.000151	CcSEcCtD
Escitalopram—Dysgeusia—Methotrexate—systemic scleroderma	0.00015	0.00015	CcSEcCtD
Escitalopram—Nausea—Lisinopril—systemic scleroderma	0.000149	0.000149	CcSEcCtD
Escitalopram—Oedema—Prednisone—systemic scleroderma	0.000149	0.000149	CcSEcCtD
Escitalopram—Anaphylactic shock—Prednisone—systemic scleroderma	0.000149	0.000149	CcSEcCtD
Escitalopram—Infection—Prednisone—systemic scleroderma	0.000148	0.000148	CcSEcCtD
Escitalopram—Back pain—Methotrexate—systemic scleroderma	0.000148	0.000148	CcSEcCtD
Escitalopram—Shock—Prednisone—systemic scleroderma	0.000147	0.000147	CcSEcCtD
Escitalopram—Nervous system disorder—Prednisone—systemic scleroderma	0.000147	0.000147	CcSEcCtD
Escitalopram—Tachycardia—Prednisone—systemic scleroderma	0.000146	0.000146	CcSEcCtD
Escitalopram—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000146	0.000146	CcSEcCtD
Escitalopram—Skin disorder—Prednisone—systemic scleroderma	0.000145	0.000145	CcSEcCtD
Escitalopram—Hyperhidrosis—Prednisone—systemic scleroderma	0.000144	0.000144	CcSEcCtD
Escitalopram—Vision blurred—Methotrexate—systemic scleroderma	0.000144	0.000144	CcSEcCtD
Escitalopram—Anorexia—Prednisone—systemic scleroderma	0.000142	0.000142	CcSEcCtD
Escitalopram—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000142	0.000142	CcSEcCtD
Escitalopram—Anaemia—Methotrexate—systemic scleroderma	0.000141	0.000141	CcSEcCtD
Escitalopram—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00014	0.00014	CcSEcCtD
Escitalopram—Rash—Mycophenolate mofetil—systemic scleroderma	0.000139	0.000139	CcSEcCtD
Escitalopram—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000139	0.000139	CcSEcCtD
Escitalopram—Headache—Mycophenolate mofetil—systemic scleroderma	0.000138	0.000138	CcSEcCtD
Escitalopram—Malaise—Methotrexate—systemic scleroderma	0.000138	0.000138	CcSEcCtD
Escitalopram—Vertigo—Methotrexate—systemic scleroderma	0.000137	0.000137	CcSEcCtD
Escitalopram—Leukopenia—Methotrexate—systemic scleroderma	0.000137	0.000137	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000136	0.000136	CcSEcCtD
Escitalopram—Insomnia—Prednisone—systemic scleroderma	0.000135	0.000135	CcSEcCtD
Escitalopram—Paraesthesia—Prednisone—systemic scleroderma	0.000134	0.000134	CcSEcCtD
Escitalopram—Cough—Methotrexate—systemic scleroderma	0.000134	0.000134	CcSEcCtD
Escitalopram—Convulsion—Methotrexate—systemic scleroderma	0.000133	0.000133	CcSEcCtD
Escitalopram—Dyspepsia—Prednisone—systemic scleroderma	0.000132	0.000132	CcSEcCtD
Escitalopram—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000131	0.000131	CcSEcCtD
Escitalopram—Myalgia—Methotrexate—systemic scleroderma	0.00013	0.00013	CcSEcCtD
Escitalopram—Arthralgia—Methotrexate—systemic scleroderma	0.00013	0.00013	CcSEcCtD
Escitalopram—Chest pain—Methotrexate—systemic scleroderma	0.00013	0.00013	CcSEcCtD
Escitalopram—Decreased appetite—Prednisone—systemic scleroderma	0.00013	0.00013	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000129	0.000129	CcSEcCtD
Escitalopram—Fatigue—Prednisone—systemic scleroderma	0.000129	0.000129	CcSEcCtD
Escitalopram—Discomfort—Methotrexate—systemic scleroderma	0.000129	0.000129	CcSEcCtD
Escitalopram—Constipation—Prednisone—systemic scleroderma	0.000128	0.000128	CcSEcCtD
Escitalopram—Confusional state—Methotrexate—systemic scleroderma	0.000126	0.000126	CcSEcCtD
Escitalopram—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000125	0.000125	CcSEcCtD
Escitalopram—Infection—Methotrexate—systemic scleroderma	0.000124	0.000124	CcSEcCtD
Escitalopram—Feeling abnormal—Prednisone—systemic scleroderma	0.000123	0.000123	CcSEcCtD
Escitalopram—Nervous system disorder—Methotrexate—systemic scleroderma	0.000122	0.000122	CcSEcCtD
Escitalopram—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000122	0.000122	CcSEcCtD
Escitalopram—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000122	0.000122	CcSEcCtD
Escitalopram—Skin disorder—Methotrexate—systemic scleroderma	0.000121	0.000121	CcSEcCtD
Escitalopram—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000121	0.000121	CcSEcCtD
Escitalopram—Anorexia—Methotrexate—systemic scleroderma	0.000119	0.000119	CcSEcCtD
Escitalopram—Urticaria—Prednisone—systemic scleroderma	0.000119	0.000119	CcSEcCtD
Escitalopram—Body temperature increased—Prednisone—systemic scleroderma	0.000118	0.000118	CcSEcCtD
Escitalopram—Abdominal pain—Prednisone—systemic scleroderma	0.000118	0.000118	CcSEcCtD
Escitalopram—Hypotension—Methotrexate—systemic scleroderma	0.000117	0.000117	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000114	0.000114	CcSEcCtD
Escitalopram—Insomnia—Methotrexate—systemic scleroderma	0.000113	0.000113	CcSEcCtD
Escitalopram—Paraesthesia—Methotrexate—systemic scleroderma	0.000112	0.000112	CcSEcCtD
Escitalopram—Dyspnoea—Methotrexate—systemic scleroderma	0.000111	0.000111	CcSEcCtD
Escitalopram—Somnolence—Methotrexate—systemic scleroderma	0.000111	0.000111	CcSEcCtD
Escitalopram—Hypersensitivity—Prednisone—systemic scleroderma	0.00011	0.00011	CcSEcCtD
Escitalopram—Dyspepsia—Methotrexate—systemic scleroderma	0.00011	0.00011	CcSEcCtD
Escitalopram—Decreased appetite—Methotrexate—systemic scleroderma	0.000109	0.000109	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000108	0.000108	CcSEcCtD
Escitalopram—Fatigue—Methotrexate—systemic scleroderma	0.000108	0.000108	CcSEcCtD
Escitalopram—Asthenia—Prednisone—systemic scleroderma	0.000107	0.000107	CcSEcCtD
Escitalopram—Pain—Methotrexate—systemic scleroderma	0.000107	0.000107	CcSEcCtD
Escitalopram—Pruritus—Prednisone—systemic scleroderma	0.000106	0.000106	CcSEcCtD
Escitalopram—Feeling abnormal—Methotrexate—systemic scleroderma	0.000103	0.000103	CcSEcCtD
Escitalopram—Diarrhoea—Prednisone—systemic scleroderma	0.000102	0.000102	CcSEcCtD
Escitalopram—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000102	0.000102	CcSEcCtD
Escitalopram—Urticaria—Methotrexate—systemic scleroderma	9.92e-05	9.92e-05	CcSEcCtD
Escitalopram—Dizziness—Prednisone—systemic scleroderma	9.88e-05	9.88e-05	CcSEcCtD
Escitalopram—Abdominal pain—Methotrexate—systemic scleroderma	9.87e-05	9.87e-05	CcSEcCtD
Escitalopram—Body temperature increased—Methotrexate—systemic scleroderma	9.87e-05	9.87e-05	CcSEcCtD
Escitalopram—Vomiting—Prednisone—systemic scleroderma	9.5e-05	9.5e-05	CcSEcCtD
Escitalopram—Rash—Prednisone—systemic scleroderma	9.42e-05	9.42e-05	CcSEcCtD
Escitalopram—Dermatitis—Prednisone—systemic scleroderma	9.41e-05	9.41e-05	CcSEcCtD
Escitalopram—Headache—Prednisone—systemic scleroderma	9.36e-05	9.36e-05	CcSEcCtD
Escitalopram—Hypersensitivity—Methotrexate—systemic scleroderma	9.2e-05	9.2e-05	CcSEcCtD
Escitalopram—Asthenia—Methotrexate—systemic scleroderma	8.96e-05	8.96e-05	CcSEcCtD
Escitalopram—Nausea—Prednisone—systemic scleroderma	8.88e-05	8.88e-05	CcSEcCtD
Escitalopram—Pruritus—Methotrexate—systemic scleroderma	8.84e-05	8.84e-05	CcSEcCtD
Escitalopram—Diarrhoea—Methotrexate—systemic scleroderma	8.55e-05	8.55e-05	CcSEcCtD
Escitalopram—Dizziness—Methotrexate—systemic scleroderma	8.26e-05	8.26e-05	CcSEcCtD
Escitalopram—Vomiting—Methotrexate—systemic scleroderma	7.94e-05	7.94e-05	CcSEcCtD
Escitalopram—Rash—Methotrexate—systemic scleroderma	7.88e-05	7.88e-05	CcSEcCtD
Escitalopram—Dermatitis—Methotrexate—systemic scleroderma	7.87e-05	7.87e-05	CcSEcCtD
Escitalopram—Headache—Methotrexate—systemic scleroderma	7.82e-05	7.82e-05	CcSEcCtD
Escitalopram—Nausea—Methotrexate—systemic scleroderma	7.42e-05	7.42e-05	CcSEcCtD
